1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,000 | 8,000 | 26.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.08. | ABL Diagnostics - Proposed Transfer of the Listing of Its Securities From the Regulated Market of Euronext Paris to Euronext Growth Paris | 774 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) (the "Company"), an international company specializing in innovative molecular biology tests and global solutions for... ► Artikel lesen | |
| 29.07. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 384 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| ABL DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 27.07. | ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital | 446 | Business Wire | Introduction of a minimum floor price of €4.50 per share for any future drawdown
Reduction of the maximum drawdown size from 50,000 to 2,500 shares
Immediate return of 98,026 loaned... ► Artikel lesen | |
| 23.07. | ABL Diagnostics acquires TEXCELL assets for €2.9 million | 1 | Investing.com | ||
| 23.07. | ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL's Operations | 379 | Business Wire | Strengthening Life Sciences and Infectious Diseases Activities at Genopole, with Synergies in Virology, Biosafety, and Biological Control
Regulatory News:
ABL Diagnostics (Euronext Paris Compartment... ► Artikel lesen | |
| 22.07. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 344 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 15.07. | ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold | 411 | Business Wire | Methodical continuation of the free float expansion strategy, in line with the commitments set forth in the 2022 Prospectus. Boosting stock liquidity and strengthening visibility among... ► Artikel lesen | |
| 10.07. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 347 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 03.07. | Dividendenbekanntmachungen (03.07.2026) | 8.912 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABL DIAGNOSTICS SA FR001400AHX6 - 0,11 EUR AGORA SA PLAGORA00067 0,5 PLN 0,1165 EUR ALBIS LEASING AG DE0006569403 - 0,1 EUR BILIA... ► Artikel lesen | |
| 02.07. | ABL Diagnostics - Approval of Dividend Distribution for Fiscal Year 2025 | 610 | Business Wire | Regulatory News:
At the Annual General Meeting of ABL Diagnostics (Paris:ABLD) held on Tuesday, June 30, 2026, at 11:00 a.m., shareholders approved all resolutions submitted for their vote, including... ► Artikel lesen | |
| 18.06. | ABL Diagnostics: Growth Trajectory Confirmed and Strong Upside Potential Identified | 459 | Business Wire | Target price: €8.7 Recommendation: Buy
Regulatory News:
ABL DIAGNOSTICS (FR001400AHX6 ABLD-FR), a leading company in the field of molecular diagnostics and genotyping, announces the... ► Artikel lesen | |
| 12.06. | ABL Diagnostics and CDL Pharma Secure a Multi-year International Contract of up to €2.7 Million Through 2031 | 484 | Business Wire | Regulatory News:
ABL Diagnostics (FR001400AHX6 "ABLD") announces the signing of a multi-year contract with a European pharmaceutical company in the field of neurodegenerative diseases. The contract... ► Artikel lesen | |
| 10.06. | ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France | 546 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) (Euronext Paris Compartment B ISIN: FR001400AHX6), a company specialized in molecular diagnostic solutions, healthcare software, and clinical sample... ► Artikel lesen | |
| 10.06. | ABL Diagnostics SA: ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Total Number of Shares Composing the Share Capital | 561 | Business Wire | (Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)
Regulatory News:
ABL Diagnostics (Paris:ABLD)
Date Total number of shares composing... ► Artikel lesen | |
| 09.06. | ABL Diagnostics: Ordinary and Extraordinary General Meeting of June 30, 2026 - Terms for Making Available or Consulting Preparatory Documents | 449 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend the Ordinary and Extraordinary General Meeting to be held on Tuesday, June 30, 2026, at 11:00... ► Artikel lesen | |
| 05.06. | ABL Diagnostics SA: ABL Diagnostics: Sale of a new block of shares by its main shareholder ABL | 466 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 04.06. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 407 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 01.06. | ABL Diagnostics Presents Its Financial Roadmap and Growth Outlook for 2026 | 407 | Business Wire | Full-year 2026 revenue target set at €12.27 million, delivering an exceptional +76.5% growth compared to 2025 Historic shift in scale driven by the full-year impact of growth drivers (FTD... ► Artikel lesen | |
| 19.05. | Allinvest Reiterates Its "BUY" Rating on ABL Diagnostics and Maintains a €8.4 Target Price (Representing a 2.2X Multiple) | 405 | Business Wire | Massive upside potential of +123.4% compared to the closing price of €3.76 (as of May 18, 2026). Historic 2025 results: Revenue up +30.4% to €6.95m, net profit surging to €0.98m (+246%)... ► Artikel lesen | |
| 18.05. | ABL Diagnostics SA: ABL Diagnostics Proposes a Significant Increase in Its Dividend for FY2025 | 364 | Business Wire | Proposed dividend of €0.11 per share, up +120%, reflecting the Company's improved financial performance and solid financial position
Regulatory News:
ABL Diagnostics (Euronext Paris FR001400AHX6)... ► Artikel lesen |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 39,260 | -1,11 % | Siemens-Healthineers-Chef: 'Mir gefällt dieses Rumgenörgel nicht' | BERLIN (dpa-AFX) - Der Vorstandvorsitzende des Dax -Konzerns Siemens Healthineers, Bernhard Montag, hat die Anspruchshaltung vieler Wirtschaftslenker in Deutschland gegenüber der Politik kritisiert.... ► Artikel lesen | |
| THERMO FISHER | 545,00 | +1,30 % | Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside? | ||
| STRATEC | 22,750 | -0,44 % | EQS-DD: STRATEC SE: Ralf Leistner, Erwerb von 29.556 Aktien der STRATEC SE von Hermann Leistner und Doris Leistner durch Schenkung | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
20.08.2026 / 18:35... ► Artikel lesen | |
| UNIDOC HEALTH | 0,052 | -7,53 % | UniDoc Health Corp.: UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform | Proposed collaboration would combine UniDoc's connected-care infrastructure with Ventripoint's AI-enabled cardiac imaging platform VANCOUVER, BC / ACCESS Newswire / August 20, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| DIASORIN | 75,46 | -0,79 % | DiaSorin Reports Lower H1 Profit, Confirms FY26 Outlook | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI) on Friday, reported lower revenue and net profit for the first half of 2026, as higher operating expenses and weaker profitability offset growth recorded... ► Artikel lesen | |
| FRESENIUS | 46,345 | +1,09 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,36 | +0,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,360 | 0,00 % | Fresenius macht bei FMC Kasse - was jetzt zählt | ||
| ALIGNMENT HEALTHCARE | 13,920 | +0,14 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| HEARTFLOW | 48,920 | -0,04 % | Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlow | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,280 | -2,00 % | 2,2 Milliarden Menschen mit Sehbeeinträchtigungen: Warum Augengesundheit für Carl Zeiss Meditec, Alcon & Co. zum Technologiemarkt wird - und wo Rise Nano Optics ins Spiel kommt | ||
| AVEANNA HEALTHCARE | 13,605 | -0,11 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| PROGYNY | 26,375 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| BILLIONTOONE | 96,27 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen |
Das Unternehmen ABL DIAGNOSTICS SA kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,140 Euro und damit 0,00 % im Plus. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,22 Euro errechnet sich eine Dividendendrendite von +10,28 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ABL DIAGNOSTICS SA finden Sie auf Wallstreet Online.